Mayer Davidson to Cardiovascular Diseases
This is a "connection" page, showing publications Mayer Davidson has written about Cardiovascular Diseases.
Connection Strength
1.817
-
The "Cost-Effective" beneficial effect of pioglitazone on cardiovascular disease. Diabetes Res Clin Pract. 2020 07; 165:108223.
Score: 0.582
-
An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug's effect on cardiovascular disease and non-alcoholic steatohepatitis. Diabetes Res Clin Pract. 2018 Jan; 135:102-110.
Score: 0.488
-
Efforts to improve subsequent treatment of cardiovascular risk factors in older patients with diabetes hospitalized for a cardiac event. Am J Manag Care. 2005 Dec; 11(12):758-64.
Score: 0.213
-
Glycemia and risk for cardiovascular disease. Ann Intern Med. 2005 Feb 01; 142(3):227; author reply 227-8.
Score: 0.201
-
Is treatment of insulin resistance beneficial independent of glycemia? Diabetes Care. 2003 Nov; 26(11):3184-6.
Score: 0.185
-
Metformin Should Not Be Used to Treat Prediabetes. Diabetes Care. 2020 09; 43(9):1983-1987.
Score: 0.148